Dispensing of Zolpidem and Low-Dose Trazodone Among Commercially Insured Adults in the US, 2011-2018
This study uses IBM MarketScan database data to describe trends in zolpidem and low-dose trazodone dispensing among adults with employer-sponsored insurance or Medicare supplemental plans between 2011 and 2018, before and after a 2017 clinical practice guideline discouraged trazodone use for insomnia.
Source: JAMA - Category: General Medicine Source Type: research
More News: Ambien | Databases & Libraries | General Medicine | Insomnia | Insurance | Medicare | Study | Trazodone